Public Markets 8 Hours

Last updated: July 23, 2026, 11:30 PM ET

Global Markets React to Geopolitical Tensions and Tech Spending

Asian stocks poised for declines as oil surged past $100 a barrel for the first time in two months amid escalating Middle East conflict fears. U.S. stocks slumped sharply following the oil price jump, with earnings from Alphabet and Tesla rekindling concerns over artificial intelligence spending. The U.S. dollar index remains in a solid uptrend, showing clear momentum turning higher according to charts. Gold declined stronger and prospects of a Federal Reserve rate hike, while the yen experienced its worst week since May, approaching 165 versus the dollar with intervention warnings proving ineffective. China’s daily stock turnover dropped to the lowest level in over three months as investors cooled on the technology sector.

Corporate Earnings and Strategic Moves Shape Sectors

Major tech earnings demonstrated AI as a fast-scaling business, despite concerns about runaway AI spending that shaved roughly $890 billion in market value from the Magnificent Seven. Intel posted its fastest growth in 15 years, with revenue jumping 25% in the second quarter, primarily fueled by AI data center demand. Meta, meanwhile, faces higher borrowing costs in its latest $12 billion data center financing, a deal led by BlackRock that met investor anxiety over rising AI exposure. HSBC is selling its Singapore insurance business to Allianz for $2.1 billion as part of its ongoing simplification strategy. SAP reported a 9.4% revenue rise but lowered operating profit guidance due to slowing growth.

India's IPO Market and Financial Regulation

Manipal Health Enterprises Ltd. is seeking to raise as much as $960 million in an initial public offering, continuing a trend of large share sales in India. In regulatory news, India's SEBI is considering allowing portfolio managers to invest clients' money overseas, including in foreign securities and IPO-bound firms. Meanwhile, Indian Prime Minister Narendra Modi to calm anger over examination paper leaks as student protests widened.

Energy Markets and Investment Trends

Oil futures edged lower following a technical correction after Brent futures settled above $100 per barrel. Overseas buyers are showing increased interest in U.S. crude amid escalating wars and concerns over adequate oil supplies. China’s gold imports rose to a two-year high in June, indicating resilient demand after international prices fell. Singapore's sovereign wealth fund GIC Pte reported its lowest five-year annualized return in over a decade, though it plans to invest $30 billion in hedge funds over the next three years.

Dealmaking and Financial Services

HSBC and Allianz have entered into an exclusive 15-year bancassurance partnership following the sale of HSBC's Singapore insurance business for $2.1 billion. Macquarie Group Ltd.'s first woman CEO, Shemara Wikramanayake, departs with a $339 million stake after leading the Australian financial conglomerate to record profits. Goldman Sachs and JPMorgan Chase & Co. have launched products allowing investors to quickly adjust exposure to tech industry debt, as concerns mount over hyperscalers' significant spending. Advent International has hired Morgan Stanley to explore a potential sale of its stake in Brazilian manufacturer Tigre SA.

Economic Activity and Policy in China

China’s central bank of liquidity to the economy in five months via its medium-term lending facility to support growth. Beijing is pursuing AI diplomacy to woo the global south with its most ambitious offer yet to build an alternative global order. Chinese AI models are expected to slash adoption costs, according to Singapore's GIC, which anticipates strong growth in Chinese AI companies but remains cautious about startups.

US Markets and Economic Indicators

Big banks are commercial real estate lending after shunning the category for years amid warnings of defaults. U.S. natural gas futures relinquished intraday gains and settled fractionally lower despite a 32 Bcf weekly inventory build. Boston Beer Company reported lower second-quarter profit as sales declined, with shipment volume decreasing.5% year-over-year. Edwards Lifesciences narrowed its full-year sales outlook after second-quarter growth, now expecting sales between $6.6 billion and $6.9 billion.